Barriers to and facilitators of hypertension management in Asmara, Eritrea: patients’ perspectives

Kotchen TA. Hypertension control: trends, approaches, and goals. Hypertension. 2007;49(1):19–20.

Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.

Karan A, Engelgau M, Mahal A. The household-level economic burden of heart disease in India. Trop Med Int Health. 2014;19(5):581–91.

Babiker FA, Elkhalifa LA, Moukhyer ME. Awareness of hypertension and factors associated with uncontrolled hypertension in Sudanese adults. Cardiovasc J Afr. 2013;24(6):208–12.

Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation. 2005;112(23):3562–8.

Bosu WK. The prevalence, awareness, and control of hypertension among workers in West Africa: a systematic review. Glob Health Action. 2015;8:26227.

Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed hypertension in sub-Saharan Africa: a systematic review and meta-analysis. Hypertension. 2015;65(2):291–8.

Addo J, Smeeth L, Leon DA. Hypertension in sub-Saharan Africa: a systematic review. Hypertension. 2007;50(6):1012–8.

Mufunda J, Nyarango P, Kosia A, Obgamariam A, Mebrahtu G, Usman A, et al. Noncommunicable diseases in Africa: a silent hypertension epidemic in Eritrea. J Hum Hypertens. 2005;19(3):255–6.

Balla SA, Abdalla AA, Elmukashfi TA, Ahmed HA. Hypertension among rural population in four states: Sudan 2012. Glob J Health Sci. 2014;6(3):206–12.

Al-Nozha MM, Arafah MR, Al-Marou YY, Al-Maatouq MA, Khan NB, Khalil MZ. Coronary artery disease in Saudi Arabia. Saudi Med J. 2004;25:1165–71.

Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 1996;275:1571–6.

Beilin J. Lifestyle and hypertension—an overview. Clin Exp Hypertens. 1999;21(5-6):749–62.

Touyz R, Campbell N, Logan A, Gledhill N, Petrella R, Padwal R. The 2004 Canadian recommendations for the management of hypertension: part III—lifestyle modifications to prevent and control hypertension. Can J Cardiol. 2004;20(1):55–9.

Ambaw D, Alemie A, Mengesha B. Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia. BMC Public Health. 2012;12(1):1.

Alsolami F, Hou X, Correa-Velez I. Factors affecting antihypertensive treatment adherence: a Saudi Arabian perspective. Clin Med Diagn. 2012;2(4):27–32.

Kretchy A, Owusu-Daaku T, Danquah A, Asampong E. A psychosocial perspective of medication side effects, experiences, coping approaches and implications for adherence in hypertension management. Clin Hypertens. 2015;21(1):1.

World Health Ranking, Live longer live better; Country profile: Eritrea. http://www.worldlifeexpectancy.com/country-health-profile/eritrea . 2014. Accessed 28 Nov 2016.

Eritrea overview. World Bank; 2016. http://www.worldbank.org/en/country/eritrea/overview . Accessed 28 Nov 2016.

Mufunda J, Mebrahtu G, Usman A, Nyarango P, Kosia A, Ghebrat Y, et al. The prevalence of hypertension and its relationship with obesity: results from a national blood pressure survey in Eritrea. J Hum Hypertens. 2006;20(1):59–65.

Usman A, Mebrahtu G, Mufunda J, Nyarang’o P, Hagos G, Kosia A, et al. Prevalence of non-communicable disease risk factors in Eritrea. Ethn Dis. 2006;16(2):542–6.

Shobana J, Semere M, Sied M, Eyob T, Russom M. Prescribing pattern of anti-hypertensive drugs among hypertension patients with cardiac complications in Eritrea. Lat Am J Pharm. 2013;32(5):745–8.

Amira C, Okubadejo U. Frequency of complementary and alternative medicine utilization in hypertensive patients attending an urban tertiary care centre in Nigeria. BMC Complement Altern Med. 2007;7(1):1.

Shafiq N, Gupta M, Kumari S, Pandhi P. Prevalence and pattern of use of complementary and alternative medicine (CAM) in hypertensive patients of a tertiary care center in India. Int J Clin Pharmacol Ther. 2003;41(7):294–8.

Songthai N, Subgranon R, Kangchai W, Rosenberg E, Hengudomsub P, Koedbangkham J. Effects of peer-support, self-management program on self-management behavior and blood pressure of older adults with essential hypertension. JMU J Nat Sci. 2014;13(3):371–82.

Assah K, Atanga N, Enoru S, Sobngwi E, Mbanya C. Community‐based peer support significantly improves metabolic control in people with type 2 diabetes in Yaoundé, Cameroon. Diabet Med. 2015;32(7):886–9.

Naanyu V, Vedanthan R, Kamano J, Rotich K, Lagat K, Kiptoo P, et al. Barriers influencing linkage to hypertension care in Kenya: qualitative analysis from the lark hypertension study. J Gen Intern Med. 2016;31(3):304–14.

Buabeng O, Matowe L, Plange-Rhule J. Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. J Pharm Pharmaceut Sci. 2004;7(3):350–2.

Mendis S, Al Bashir I, Dissanayake L, Varghese C, Fadhil I, Marhe E, et al. Gaps in capacity in primary care in low-resource settings for implementation of essential noncommunicable disease interventions. Int J Hypertens. 2012;2012:1–7.

Risso-Gill I, Balabanova D, Majid F, Ng K, Yusoff K, Mustapha F, et al. Understanding the modifiable health systems barriers to hypertension management in Malaysia: a multi-method health systems appraisal approach. BMC Health Serv Res. 2015;15(1):254.